Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Michael R Gold Added: 6 years ago
Michael Gold from Medical University of South Carolina, Charleston, SA, S-ICD Registry: Subcutaneous ICD (S-ICD) Post-market approval study. Filmed by Radcliffe Cardiology on-site at HRS 2017. View more
Author(s): Thomas A Turnage , John A Kpaeyeh , Michael R Gold Added: 3 years ago
Introduction Implantable cardioverter-defibrillators (ICD) demonstrate a mortality reduction in patients at risk for sudden cardiac death.1–4 Transvenous lead placement with a subcutaneous, pectoral pulse generator has been the standard approach for ICD implantation for the past two decades,5 and have a high rate of successful implantation and a very low risk of in-hospital mortality.6 Despite… View more
Dr Grace has developed one of the largest clinical practices in cardiac arrhythmia management in the UK and specialises in catheter ablation techniques particularly for atrial fibrillation. Dr Grace trained in medicine at St Thomas’ Hospital in London completing his PhD in Cambridge with post-doctoral studies as a Fulbright Scholar at the University of California. He was appointed Consultant… View more
Foreword

Article

Author(s): Donald E Cutlip Added: 3 years ago
The Editorial Board and staff are pleased to present the latest issue of US Cardiology Review. There are 12 very relevant review papers covering four cardiovascular subspecialties. The issue leads with an update on heart failure with preserved ejection by Drs Birati and Soni, and is followed by a review of fulminant myocarditis by Dr Seif and colleagues. The early recognition and guided therapy… View more
Job title: Consultant Cardiologist
Dr Archana Rao serves as a Consultant Cardiologist at the Liverpool Heart and Chest Hospital. She is a heart failure specialist who performs complex device and lead extraction procedures in addition to leadless pacing, subcutaneous ICDs and His bundle pacing. Dr Rao has performed over 3,000 ICD implantations and over 500 system extractions, and she has implanted more than 1,500 permanent… View more
Author(s): Michael R Gold Added: 3 years ago
Dr Michael R Gold (Medical University of South Carolina, Charleston, SC, US) discusses the primary results of the UNTOUCHED trial. The UNTOUCHED trial assesed the 18-month incidence of inappropriate shocks in subjects implanted with the EMBLEM Subcutaneous Implantable Defibrillator (S-ICD) for primary prevention of sudden cardiac death. Questions: 1. What was the rationale behind the UNTOUCHED… View more
Author(s): G Michael Felker , Christopher B Granger Added: 3 years ago
Chronic heart failure is common, disabling and deadly. It affects approximately five million people in the US and accounts for over one million hospitalizations annually.1 Despite continued improvements in heart failure therapy, mortality over five years is approximately 50%.2 This article summarizes significant recent developments in pharmacologic and device therapy for heart failure. … View more
Added: 1 year ago
In this interview, Dr Joanna Osmanska (University of Glasgow, UK) outlines the findings of the SUBCUT-HF I (NCT04846816)and the SQI 01-01 studies (NCT04384653). The studies, presented at Heart Failure 2022, demonstrated that the novel subcutaneous furosemide resulted in similar efficacy in terms of diuresis and natriuresis when compared to intravenous furosemide.In addition to this the… View more
Author(s): Paolo Della Bella Added: 2 years ago
In this short interview from ACC.22, Dr Paolo Della Bella (San Raffaele University-Hospital, IT) joins us to discuss the findings of the PARTITA trial (NCT01547208). The aim of this study was to determine whether the burden of ventricular tachycardia correlates with ICD shock therapies and if the timing of VT ablation affects patient prognosis. Discussion Points: Rationale behind this trial … View more